Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
Mallinckrodt
McKinsey
Johnson and Johnson
Baxter

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for ATN-161

See Plans and Pricing

« Back to Dashboard

Drug Development Status for ATN-161: Sponsors, patents, clinical trial progress

ATN-161 is an investigational drug.

There have been 21 clinical trials for ATN-161. The most recent clinical trial was a Phase 2 trial, which was initiated on November 15th 2018.

The most common disease conditions in clinical trials are Acute Kidney Injury, HIV Infections, and Renal Insufficiency. The leading clinical trial sponsors are Attenuon, Westat, and Ablynx.

There are eighteen US patents protecting this investigational drug and two hundred and forty-six international patents.

Recent Clinical Trials for ATN-161
TitleSponsorPhase
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO TrialInstitute of Liver and Biliary Sciences, IndiaN/A
FURosemide Stress Test to Predict Need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in ICUAssistance Publique - Hôpitaux de ParisPhase 4
Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead InRoche Pharma AGPhase 1/Phase 2

See all ATN-161 clinical trials

Clinical Trial Summary for ATN-161

Top disease conditions for ATN-161
Top clinical trial sponsors for ATN-161

See all ATN-161 clinical trials

US Patents for ATN-161

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ATN-161   Start Trial Fluorinated integrin antagonists SciFluor Life Sciences, Inc. (Cambridge, MA)   Start Trial
ATN-161   Start Trial Nonanoic and decanoic acid derivatives and uses thereof SciFluor Life Sciences, Inc. (Cambridge, MA)   Start Trial
ATN-161   Start Trial Method of making tetrahydronaphthyridinyl nonanoic acid compounds SciFluor Life Sciences, Inc. (Cambridge, MA)   Start Trial
ATN-161   Start Trial Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof SciFluor Life Sciences, Inc. (Cambridge, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Mallinckrodt
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.